Abstract:Background Periodontal disease poses a significant oral health challenge, involving inflammatory conditions impacting tooth-supporting structures. Treponema denticola, a "red complex" organism, plays a crucial role in periodontal pathogenesis, forming biofilms in subgingival environments and contributing to dysbiosis. Antimicrobial therapy is pivotal in managing periodontal disease, requiring a nuanced understanding of susceptibility patterns exhibited by key pathogens like T. denticola. Aims and objectives This study aims to investigate the antimicrobial susceptibility and resistance profiles of Treponema denticola, a prominent bacterium in periodontal disease, by examining its responses to various antimicrobial agents commonly used in periodontal therapy. Methodology Plaque samples were meticulously collected from individuals diagnosed with periodontal disease to ensure a diverse representation of the oral microbiome. All the samples were cultured, and red complex bacteria were isolated under anaerobic culture. Treponema denticola isolates were cultured from these samples under anaerobic conditions, and molecular techniques were employed for species identification. A comprehensive panel of antimicrobial agents was selected to assess the response of Treponema denticola. In vitro antimicrobial susceptibility testing (AST) was conducted using the antimicrobial gradient method, employing a hybrid approach combining elements of disk-diffusion and dilution methods. Results Treponema denticola had exhibited resistance to metronidazole, a commonly used antibiotic effective against anaerobic bacteria, emphasizing limitations in its applicability. However, the bacterium displayed sensitivity to tetracycline, imipenem, cefoperazone, chloramphenicol, clindamycin, and moxifloxacin, offering diverse therapeutic options. The antimicrobial gradient strip test provided detailed minimum inhibitory concentration (MIC) values, contributing to a nuanced understanding of susceptibility and resistance patterns. Conclusion This study significantly advances our understanding of Treponema denticola's antimicrobial susceptibility and resistance profiles in the context of periodontal disease. The findings underscore the importance of tailored treatment strategies and contribute to broader efforts in antimicrobial stewardship, aligning with global initiatives to combat antibiotic resistance. This research lays the foundation for more effective and personalized approaches to periodontal care, emphasizing the intricate microbial dynamics associated with periodontal health and disease.

Review on the Susceptibility and Antimicrobial Resistance of Periodontal Pathogenes to Antimicrobial Agents

Research progress on resistance of predominant periodontal anaerobes

Antibiotic resistance in the microbiota of periodontitis patients: an update of current findings

Advances in novel therapeutic approaches for periodontal diseases

Antimicrobial Resistance and New Antimicrobial Agents, A Review of the Literature

Nanoparticles in Periodontitis Therapy: A Review of the Current Situation

Evaluation of Antimicrobial Susceptibility and Resistance Patterns of Treponema denticola Isolated From Periodontal Disease: An In Vitro Study

Inhibition of pathogenic microbes in oral infectious diseases by natural products: Sources, mechanisms, and challenges

Antimicrobial resistance and prevalence of resistance genes of obligate anaerobes isolated from periodontal abscesses.

The Susceptibility of Oral Bacterial Biofilms to Antimicrobial Agents

Application of Antibiotics/Antimicrobial Agents on Dental Caries

Advanced biomaterials and their potential applications in the treatment of periodontal disease

Therapeutic Strategies and Genetic Implications for Periodontal Disease Management: A Systematic Review

Antimicrobial Activity and Resistance: Influencing Factors

Recent advances in antibacterial agents

Europe's contribution to the evaluation of the use of systemic antimicrobials in the treatment of periodontitis

Novel Bioactive and Therapeutic Dental Polymeric Materials to Inhibit Periodontal Pathogens and Biofilms

Mechanisms of resistance to selected antibiotics in Acinetobacter baumannii

The Role and Research Progress of Drug-Resistant Oral Microorganisms in the Pathogenesis of Periodontitis

New insights into nanotherapeutics for periodontitis: a triple concerto of antimicrobial activity, immunomodulation and periodontium regeneration

Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review